CIK 0001785530 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Werewolf Therapeutics, Inc.
Sign in to watch- Ticker
- HOWL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823523180
- Phone
- 617-952-0555
- Business address
- 303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Material agreement
- 8-K Event Other events
- 8-K Event Results of operations
- 8-K Event Auditor change
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · New debt or obligation · Executive or director change
- 8-K Event Material agreement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Material agreement · New debt or obligation
Page 3 of 4 · 62 filings